Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.
about
Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries' prescription utilization and expendituresThe Affordable Care Act and Diabetes Diagnosis and Care: Exploring the Potential ImpactsMedicare Part D and quality of prescription medication use in older adultsMethodological issues in using multiple years of the Medicare current beneficiary surveyOral antineoplastic agents: how do we care about adherence?Functional Limitations, Medication Support, and Responses to Drug Costs among Medicare BeneficiariesIdentifying patients with cost-related medication non-adherence: a big-data approachEstimating model-adjusted risks, risk differences, and risk ratios from complex survey data.Medicare beneficiary knowledge of the Part D program and its relationship with voluntary enrollment.The effect of depression and cognitive impairment on enrollment in Medicare Part D.Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.Medicare Part D coverage gap and diabetes beneficiaries.Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetesThe effect of Medicare Part D on drug and medical spending.Dirt cheap and without prescription: how susceptible are young US consumers to purchasing drugs from rogue internet pharmacies?The Medicare drug benefit (Part D) and treatment of heart failure in older adults.Polypharmacy in the HIV-infected older adult population.Pilot assessment of patient satisfaction and clinical impact of Medicare Part D in diabetic geriatric patientsWhy some disabled adults in Medicaid face large out-of-pocket expensesInhaler costs and medication nonadherence among seniors with chronic pulmonary disease.Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic reviewA systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity.Managing medications in clinically complex elders: "There's got to be a happy medium".Impact of generic substitution decision support on electronic prescribing behaviorFactors influencing cost-related nonadherence to medication in older adults: a conceptually based approachAssociation of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.The differential rates in cost-related non-adherence to medical care by gender in the US adult population.Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse?Living arrangements, chronic diseases, and prescription drug expenditures among Korean elderly: vulnerability to potential medication underuse.Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations.Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study.Conducting high-value secondary dataset analysis: an introductory guide and resources.Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions.Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007Effects of eliminating drug caps on racial differences in antidepressant use among dual enrollees with diabetes and depressionDid Medicare Part D reduce disparities?Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression.The effect of cost on adherence to prescription medications in Canada.
P2860
Q24655747-AF61100B-C9B9-4778-B46A-E48F2BECE6FAQ26764842-1A29E561-031A-48F0-A604-C81BD256BC3FQ27023843-BC32B891-EAEE-43D6-A701-518ED6313FD0Q27691813-6FCB9AA1-BFFD-4466-8864-E326265A5B4EQ28082909-1448BD7B-5F18-4CEB-A979-2AF7D023738AQ28551392-F969FDD3-57C8-434F-9043-B2B0C824A7F7Q31070358-2AE791BA-A1BE-4FCF-9992-1DA863B7DBDBQ33529559-962B7949-E3A1-47A2-8E5A-5C0271E3B917Q33551939-DAEFD601-FDCB-427E-AA0D-3851539C64AAQ33605815-3BFECEBB-2160-4B84-A88D-72803037E298Q33611387-40D6E9D9-9DD0-4F15-B26F-8406642393F0Q33667931-6F4054D3-AFD9-462D-91B1-D11980A83FBCQ33725773-F61145E9-35D2-4229-B143-8F10D470B8D4Q33810332-7DB73946-EB87-4851-95E7-062C54E1B538Q33913729-7002CA91-A38A-4066-800F-C675F6041151Q33967679-CCD871E0-AC93-40DB-A4CF-2C14629F9678Q34037407-DB6719B4-85AD-4AAD-9E47-A1660C1260E6Q34105359-2EA40786-1CFC-4E06-9DF9-BAFE8BAF9A75Q34116511-AE665376-0FBD-4E9F-9CA2-B36CA157956EQ34130699-3402147F-AD3C-4A8C-95F4-7FA686AAC652Q34158480-5CDFAF08-39F3-4C8D-8AAC-23798C747965Q34175208-25BA3E2C-A42B-4C24-8E0B-10ABF6D5E4AFQ34311242-B64B1D2C-F1AB-4CB6-BDB3-7FF1652706D3Q34399756-0CBB0CD7-84DF-47A9-9161-21F826A8AD5EQ34454355-E4CB4827-4AA1-4161-BB8F-357B17F03D19Q34529920-9191AE7A-2A77-4FB8-A7EA-26C31818103CQ34556163-07F6C38F-0D93-4F73-AA78-0006B23FEB26Q34886245-7271C405-299B-4D38-A0E7-6318CEF397B6Q34957623-DE41F67C-43FF-487E-963C-C67D60D7681FQ34993573-CD65495F-114C-4F5B-BB32-197BA88DBAA8Q34996381-96A4CBED-45B9-4BDD-B691-7817C68A2D7CQ35060868-9F19D4A1-BB88-4C72-9DB9-0B58B2C4BD2EQ35073728-55992385-353C-4CDA-B031-4110635B0BEDQ35113156-EB682FFC-3BFF-4183-925C-2F0BF2F1B788Q35120287-E536F815-003A-4EDA-B29F-FC920CD2DC00Q35151469-824CCB86-A3A6-4059-A9BB-365E516682E4Q35328635-BCE2813C-E46B-47C7-B546-B59C171AA196Q35509973-B46F6A69-F043-4F82-A30D-6881192F40B4Q35602002-F2EA0C1A-F11E-48EE-B402-7719152CFDF8Q35761548-18EA0007-1EBF-4BED-BA1B-18BB69474892
P2860
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cost-related medication nonadh ...... ementation of Medicare Part D.
@en
Cost-related medication nonadh ...... ementation of Medicare Part D.
@nl
type
label
Cost-related medication nonadh ...... ementation of Medicare Part D.
@en
Cost-related medication nonadh ...... ementation of Medicare Part D.
@nl
prefLabel
Cost-related medication nonadh ...... ementation of Medicare Part D.
@en
Cost-related medication nonadh ...... ementation of Medicare Part D.
@nl
P2093
P2860
P356
P1476
Cost-related medication nonadh ...... ementation of Medicare Part D.
@en
P2093
Alyce S Adams
Amy J Graves
Becky A Briesacher
Dana Gelb Safran
Fang Zhang
Gerald S Adler
Jeanne M Madden
Jerry H Gurwitz
Marsha Pierre-Jacques
Stephen B Soumerai
P2860
P304
P356
10.1001/JAMA.299.16.1922
P407
P577
2008-04-01T00:00:00Z